Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E4FM
|
|||
Former ID |
DNC003212
|
|||
Drug Name |
Y-700
|
|||
Synonyms |
niraxostat; Piraxostat; Y-700; UNII-246FR6022S; CHEMBL169526; 206884-98-2; 1-[3-CYANO-4-(NEOPENTYLOXY)PHENYL]-1H-PYRAZOLE-4-CARBOXYLIC ACID; 246FR6022S; YSH; 1-(3-cyano-4-neopentyloxyphenyl) pyrazole-4-carboxylic acid; 1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]-1h-pyrazole-4-carboxylic acid; Niraxostat [INN]; Y 700; AC1L9MN7; MLS006010327; SCHEMBL440021; ZINC7343; DTXSID70174747; AETHRPHBGJAIBT-UHFFFAOYSA-N; MolPort-005-943-250; BDBM50098068; DB03841; NCGC00263135-01; ACM206884982; SMR004701391; FT-0728443
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Gout [ICD-11: FA25; ICD-10: M10] | Discontinued in Phase 2 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H17N3O3
|
|||
Canonical SMILES |
CC(C)(C)COC1=C(C=C(C=C1)N2C=C(C=N2)C(=O)O)C#N
|
|||
InChI |
1S/C16H17N3O3/c1-16(2,3)10-22-14-5-4-13(6-11(14)7-17)19-9-12(8-18-19)15(20)21/h4-6,8-9H,10H2,1-3H3,(H,20,21)
|
|||
InChIKey |
AETHRPHBGJAIBT-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 206884-98-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Xanthine dehydrogenase/oxidase (XDH) | Target Info | Inhibitor | [2] |
BioCyc | Purine nucleotides degradation | |||
Urate biosynthesis/inosine 5'-phosphate degradation | ||||
Guanosine nucleotides degradation | ||||
Adenosine nucleotides degradation | ||||
Retinoate biosynthesis II | ||||
KEGG Pathway | Purine metabolism | |||
Caffeine metabolism | ||||
Drug metabolism - other enzymes | ||||
Metabolic pathways | ||||
Peroxisome | ||||
Panther Pathway | Adenine and hypoxanthine salvage pathway | |||
Purine metabolism | ||||
Pathwhiz Pathway | Caffeine Metabolism | |||
Purine Metabolism | ||||
Reactome | Purine catabolism | |||
WikiPathways | Oxidative Stress | |||
Effects of Nitric Oxide | ||||
Metabolism of nucleotides | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010582) | |||
REF 2 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.